Vertex Pharmaceuticals is a U.S. biopharmaceutical enterprise engaged in the development and commercialization of prescription drugs. Its primary approved products are used to treat cystic fibrosis. Additionally, the company has clinical-stage product candidates in sickle cell disease, thalassemia, acute pain, and specific kidney diseases. The company combines internal R&D platforms with external corporate partnerships to advance the clinical validation and regulatory review processes of targeted therapies.